TrialAntimicrobial agents and chemotherapy2019

Characterization of β-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against β-Lactamase Producers.

Rodrigo E Mendes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.